Xortx Therapeutics Inc
(XRTX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 11-2004 | 08-2004 | 05-2004 | 02-2004 | 08-2003 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -122,245 | -130,453 | 22,928 | 17,871 | 16,657 |
| Depreciation Amortization | 6,505 | 4,663 | 2,910 | 1,193 | 3,562 |
| Income taxes - deferred | -7,709 | -3,510 | 3,400 | 1,682 | 93 |
| Accounts receivable | -6,695 | -7,314 | -4,728 | 1,901 | 339 |
| Accounts payable and accrued liabilities | 4,251 | 8,114 | 2,416 | 3,009 | 2,050 |
| Other Working Capital | -16,679 | -20,196 | -21,484 | -8,448 | 5,844 |
| Other Operating Activity | 165,409 | 160,716 | -3,724 | -10,946 | -2,294 |
| Operating Cash Flow | $22,837 | $12,020 | $1,718 | $6,262 | $26,251 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -8,949 | -6,403 | -3,730 | -1,292 | -3,499 |
| Net Acquisitions | -7,418 | -5,979 | -6,015 | -5,585 | -325 |
| Other Investing Activity | 6,000 | 6,000 | 0 | 0 | 0 |
| Investing Cash Flow | $-10,367 | $-6,382 | $-9,745 | $-6,877 | $-3,824 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | -3,000 | N/A | N/A | N/A |
| Debt Repayment | -4,133 | -133 | 1,841 | -1,133 | -12,613 |
| Common Stock Issued | 53,150 | 52,984 | 4,255 | 3,550 | N/A |
| Financing Cash Flow | $49,017 | $49,851 | $6,096 | $2,417 | $-12,613 |
| Beginning Cash Position | 2,008 | 2,008 | 2,008 | 2,008 | 455 |
| End Cash Position | 63,495 | 57,497 | 77 | 3,810 | 9,363 |
| Net Cash Flow | $61,487 | $55,489 | $-1,931 | $1,802 | $8,908 |
| Free Cash Flow | |||||
| Operating Cash Flow | 22,837 | 12,020 | 1,718 | 6,262 | 26,251 |
| Capital Expenditure | -8,985 | -6,403 | -3,766 | -1,328 | -3,499 |
| Free Cash Flow | 13,852 | 5,617 | -2,048 | 4,934 | 22,752 |